Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Shiho, Chiba"'
Autor:
Shiho Chiba, Maki Kiso, Shinya Yamada, Kazuhiko Someya, Yoshikuni Onodera, Aya Yamaguchi, Satoko Matsunaga, Ryuta Uraki, Kiyoko Iwatsuki-Horimoto, Seiya Yamayoshi, Fumihiko Takeshita, Yoshihiro Kawaoka
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-5 (2024)
Abstract Highly pathogenic avian influenza (HPAI) H5 viruses from different clades have been circulating globally, threatening wild/domestic birds and mammals. Given frequent spillovers and high mortality among mammals, coupled with our inability to
Externí odkaz:
https://doaj.org/article/a8e9d82e3fbb44448a879af00151cfac
Autor:
Chunyang Gu, Shufang Fan, Randall Dahn, Lavanya Babujee, Shiho Chiba, Lizheng Guan, Tadashi Maemura, David Pattinson, Gabriele Neumann, Yoshihiro Kawaoka
Publikováno v:
EBioMedicine, Vol 101, Iss , Pp 105034- (2024)
Summary: Background: In 2022 and 2023, novel reassortant H3N8 influenza viruses infected three people, marking the first human infections with viruses of this subtype. Methods: Here, we generated one of these viruses (A/Henan/4-10CNIC/2022; hereafter
Externí odkaz:
https://doaj.org/article/66b037640aba4a0e9acf2b8091c1615f
Autor:
Ryuta Uraki, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Seiya Yamayoshi, Mutsumi Ito, Shiho Chiba, Yuko Sakai-Tagawa, Masaki Imai, Yukie Kashima, Michiko Koga, Noriko Fuwa, Nobumasa Okumura, Masayuki Hojo, Noriko Iwamoto, Hideaki Kato, Hideaki Nakajima, Norio Ohmagari, Hiroshi Yotsuyanagi, Yutaka Suzuki, Yoshihiro Kawaoka
Publikováno v:
Cell Reports, Vol 42, Iss 12, Pp 113580- (2023)
Summary: EG.5.1 is a subvariant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron XBB variant that is rapidly increasing in prevalence worldwide. However, the pathogenicity, transmissibility, and immune evasion properties of
Externí odkaz:
https://doaj.org/article/3359de53c5544266aee6bf7bded1cffe
Publikováno v:
mBio, Vol 14, Iss 4 (2023)
ABSTRACT Vaccination is the most effective countermeasure to reduce the severity of influenza. Current seasonal influenza vaccines mainly elicit humoral immunity targeting hemagglutinin (HA). In particular, the amino acid residues around the receptor
Externí odkaz:
https://doaj.org/article/42fbb3b96e1946b1af12706f441f7b4c
Autor:
Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Moe Okuda, Michiko Ujie, Atsuhiro Yasuhara, Jurika Murakami, Calvin Duong, Taiki Hamabata, Mutsumi Ito, Shiho Chiba, Ryo Kobayashi, Satoshi Takahashi, Keiko Mitamura, Masao Hagihara, Akimichi Shibata, Yoshifumi Uwamino, Naoki Hasegawa, Toshiaki Ebina, Akihiko Izumi, Hideaki Kato, Hideaki Nakajima, Norio Sugaya, Yuki Seki, Asef Iqbal, Isamu Kamimaki, Masahiko Yamazaki, Yoshihiro Kawaoka, Yuki Furuse
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 11, Pp 2198-2205 (2022)
Japan has reported a relatively small number of COVID-19 cases. Because not all infected persons receive diagnostic tests for COVID-19, the reported number must be lower than the actual number of infections. We assessed SARS-CoV-2 seroprevalence by a
Externí odkaz:
https://doaj.org/article/9adaa9f3408440039258cdaea67161f0
Autor:
Shiho Chiba, Steven J. Frey, Peter J. Halfmann, Makoto Kuroda, Tadashi Maemura, Jie E. Yang, Elizabeth R. Wright, Yoshihiro Kawaoka, Ravi S. Kane
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-9 (2021)
Chiba et al. describe the use of MS2 bacteriophage coat proteins to develop nanocarriers that display the SARS-CoV-2 spike proteins multivalently for vaccine applications. The vaccine elicited high neutralizing antibody titers and protected Syrian ha
Externí odkaz:
https://doaj.org/article/eccc0e36630d4307b1d6da12b00abf09
Autor:
Shiho Chiba, Peter J. Halfmann, Masato Hatta, Tadashi Maemura, Shufang Fan, Tammy Armbrust, Olivia M. Swartley, LaTasha K. Crawford, Yoshihiro Kawaoka
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 2, Pp 660-663 (2021)
Severe acute respiratory syndrome coronavirus 2 readily transmits between domestic cats. We found that domestic cats that recover from an initial infection might be protected from reinfection. However, we found long-term persistence of inflammation a
Externí odkaz:
https://doaj.org/article/8d2796af5b9f47a58a96fc41ebd38016
Autor:
Shiho Chiba, Maki Kiso, Noriko Nakajima, Shun Iida, Tadashi Maemura, Makoto Kuroda, Yuko Sato, Mutsumi Ito, Moe Okuda, Shinya Yamada, Kiyoko Iwatsuki-Horimoto, Tokiko Watanabe, Masaki Imai, Tammy Armbrust, Ralph S. Baric, Peter J. Halfmann, Tadaki Suzuki, Yoshihiro Kawaoka
Publikováno v:
mBio, Vol 13, Iss 1 (2022)
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide since December 2019, causing coronavirus disease 2019 (COVID-19). Although vaccines for this virus have been developed rapidly, repurposing drugs approved to t
Externí odkaz:
https://doaj.org/article/b06f8d8ad736460ead83f0867cc3f591
Autor:
Peter J. Halfmann, Ana Castro, Kathryn Loeffler, Steven J. Frey, Shiho Chiba, Yoshihiro Kawaoka, Ravi S. Kane
Publikováno v:
Bioengineering & Translational Medicine, Vol 6, Iss 3, Pp n/a-n/a (2021)
Abstract The persistence of the global severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic has brought to the forefront the need for safe and effective vaccination strategies. In particular, the emergence of several variants wit
Externí odkaz:
https://doaj.org/article/9cec3caf6d7e42f0b9f520b5ca7c4b47
Autor:
Seiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, Osamu Akasaka, Morio Nakamura, Ichiro Nakachi, Michiko Koga, Keiko Mitamura, Kazuma Yagi, Kenji Maeda, Hideaki Kato, Masanori Nojima, David Pattinson, Takayuki Ogura, Rie Baba, Kensuke Fujita, Hiroyuki Nagai, Shinya Yamamoto, Makoto Saito, Eisuke Adachi, Junichi Ochi, Shin-ichiro Hattori, Tetsuya Suzuki, Yusuke Miyazato, Shiho Chiba, Moe Okuda, Jurika Murakami, Taiki Hamabata, Kiyoko Iwatsuki-Horimoto, Hideaki Nakajima, Hiroaki Mitsuya, Norio Omagari, Norio Sugaya, Hiroshi Yotsuyanagi, Yoshihiro Kawaoka
Publikováno v:
EClinicalMedicine, Vol 32, Iss , Pp 100734- (2021)
Background: To develop an effective vaccine against a novel viral pathogen, it is important to understand the longitudinal antibody responses against its first infection. Here we performed a longitudinal study of antibody responses against SARS-CoV-2
Externí odkaz:
https://doaj.org/article/93fc7a3385ff4a548da167956b32908b